Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
Insulin Glargine 100 Iu Oblique Ml Pen Of 3 Ml,Insulin Pen Resuable Device For Insulin Cartridge,In
|
| Description |
|
| Organisation | Department of Military Affairs | Ministry of Defence |
| Tender Id | GEM/2024/B/5217832 |
|
Reference Number |
- |
| Tender Fee | - |
| EMD | - |
| Tender Value | - |
| Place | |
| Link |
View Original Tender Notice
https://bidplus.gem.gov.in/all-bids |
| Start Date | July 28, 2024 23:42 |
| End Date |
Expired
19/08/2024
Expired 790 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Award of Contract & Bid Results
Technical Evaluation Results
| S.No. | Seller Name | Offered Item | Participated On | MSE/MII Status | Status |
|---|---|---|---|---|---|
| 1 | AAP PHARMA | - | 18-08-2024 13:21:44 | MSE | Evaluated |
| 2 | Goyal Medical & General Agency | - | 17-08-2024 19:07:59 | MSE | Evaluated |
| 3 | JAIPUR AGENCIES | - | 17-08-2024 20:52:39 | MSE | Evaluated |
| 4 | KANAK ENTERPRISES | - | 19-08-2024 09:33:13 | MSE | Evaluated |
| 5 | KHUSHBOO PHARMA | - | 19-08-2024 10:22:56 | MSE | Evaluated |
| 6 | S.S. ENTERPRISES | - | 18-08-2024 18:55:37 | MSE | Evaluated |
| 7 | SRI SAI AGENCIES | - | 17-08-2024 19:54:43 | MSE | Evaluated |
| 8 | YAXON BIO CARE PRIVATE LIMITED | - | 08-08-2024 17:46:17 | MSE | Evaluated |
Hq_med_drugs_zrc_zonal rate contract for supply of (ph no.:10031) insulin glargine monocomponent 100 iu/ml injection - 3 ml pen
Hq_med_drugs_zrc_zonal rate contract for supply of (ph no.:10031) insulin glargine monocomponent 100 iu/ml injection - 3 ml pen
Read moreInj insulin - human mixtard 70/30 100 iu/10 ml
Inj insulin - human mixtard 70/30 100 iu/10 ml
Read moreInsulin glargine (300 units/per ml) 1.5 ml injection.
Insulin glargine (300 units/per ml) 1.5 ml injection.
Read moreRabies human monoclonal antibody (rdna) 40 iu/ml (100 iu/2.5 ml vial)
Rabies human monoclonal antibody (rdna) 40 iu/ml (100 iu/2.5 ml vial)
Read moreHq_med_drugs_gte_zrc_zonal rate contract for supply of (ph no.:10088) insulin degludec 100 u/ml - 3 ml pre filled pen
Hq_med_drugs_gte_zrc_zonal rate contract for supply of (ph no.:10088) insulin degludec 100 u/ml - 3 ml pre filled pen
Read more(ph no.:10013) human insulin mix.of 30/70 (rdna origin) 40 iu/ml - 10 ml inj.
(ph no.:10013) human insulin mix.of 30/70 (rdna origin) 40 iu/ml - 10 ml inj.
Read moreHq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml
Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml
Read moreHq_med_sur_(ph no.:31034) disp. syringes 1 ml with needle 30 g - 40 iu/ ml for insulin
Hq_med_sur_(ph no.:31034) disp. syringes 1 ml with needle 30 g - 40 iu/ ml for insulin
Read moreInj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.
Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.
Read moreof your Industry type